Author:
Shimada Hideaki,Nagata Matsuo,Cho Akihiro,Takiguchi Nobuhiro,Kainuma Osamu,Soda Hiroaki,Ikeda Atsushi,Nabeya Yoshihiro,Yajima Satoshi,Yamamoto Hiroshi,Sugiyama Takahiro,Itami Makiko
Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. von Brevern MC, Hollstein MC, Cawley HM, De Benedetti VM, Bennett WP, Liang L, et al. Circulating anti-p53 antibodies in esophageal cancer patients are found predominantly in individuals with p53 core domain mutations in their tumors. Cancer Res. 1996;56:4917–21.
2. Hagiwara N, Onda M, Miyashita M, Sasajima K. Detection of circulating anti-p53 antibodies in esophageal cancer patients. J Nippon Med Sch. 2000;67:110–7.
3. Shimada H, Takeda A, Arima M, Okazumi S, Matsubara H, Nabeya Y, et al. Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma. Cancer. 2000;89:1677–83.
4. Shimada H, Shiratori T, Takeda A, Matsushita K, Okazumi S, Akutsu Y, et al. Perioperative changes of serum p53 antibody titer is a predictor for survival in patients with esophageal squamous cell carcinoma. World J Surg. 2009;33:272–7.
5. Shimada H, Ochiai T. Molecular diagnosis and treatment for esophageal carcinoma with p53. Esophagus. 2007;4:165–8.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献